Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,865 across all filing types
Latest filing 2018-04-27 Regulatory Filings
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Galapagos presents strong disease-modifying effects in preclinical model of osteoarthritis with GLPG1972 at OARSI 2018
Regulatory Filings Classification · 90% confidence The document is a press release, dated April 27, 2018, announcing the presentation of preclinical and Phase 1 study results for a drug candidate (GLPG1972) at a scientific conference (OARSI 2018). It details scientific findings, mentions future plans (Phase 2 study start), and includes standard boilerplate language about the company (Galapagos) and forward-looking statements, referencing SEC filings like the 20-F. This format is characteristic of an initial announcement of scientific or clinical progress, often released to the public and investors before or concurrent with a formal earnings report or regulatory filing. It is not a full Annual Report (10-K), a formal Audit Report (AR), or a transcript (CT). Since it is an announcement of results and development progress, it fits best under the general category for investor-focused updates that aren't strictly earnings releases (ER) or formal presentations (IP). Given the content focuses on drug development milestones and scientific data presentation, it is most closely aligned with an Investor Presentation (IP) or a general Regulatory Filing (RNS) if it were purely administrative. However, because it is a detailed announcement of scientific data and development progress intended for investors and the scientific community, 'Investor Presentation (IP)' is a strong candidate, although it is structured as a press release. Since it is a press release announcing scientific data and development milestones, and not the presentation slides themselves, it functions as a high-level update. In the context of the provided definitions, it is a specific type of corporate communication. It is not a formal financial report (10-K, IR, ER). It is an announcement of scientific findings, which often accompanies or precedes an Investor Presentation. Given the options, and recognizing this is a press release detailing scientific data, it is often categorized as a general regulatory announcement or an investor update. Since it details specific data points and future plans, it leans towards an Investor Presentation (IP) or a Regulatory Filing (RNS) as a fallback. Given the detailed nature of the scientific update, I will classify it as an Investor Presentation (IP) as it serves that function, even if it's delivered via a press release format, or RNS if it's considered a general announcement. Since it is a detailed announcement of data intended for investors, IP is plausible. However, if we strictly follow the 'announcement vs. document' rule, this is an announcement. Let's re-evaluate: It is a press release announcing data presented elsewhere. This is a common format for corporate updates. It is not a DEF 14A, DIRS, DIV, etc. It is a scientific/development update. It is not a formal Earnings Release (ER) as it focuses on R&D, not revenue/profit. It is not a formal Investor Presentation (IP) document, but an announcement *about* presentations. Therefore, the most appropriate general category for a non-standard, non-financial regulatory announcement is RNS (Regulatory Filings/Miscellaneous).
2018-04-27 English
6-K Filing
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, Galapagos NV. It includes detailed results from the Annual Shareholders' Meeting, such as approval of annual accounts, remuneration report, release from liability, re-appointment of directors, remuneration of directors, and offer of warrants. It also references the announcement of unaudited first quarter results and includes exhibits like a press release and a first quarter report. The primary content is the official results of shareholder votes at the Annual General Meeting, which fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is over 6000 characters and contains substantive information, not just an announcement of a report, so it is not RPA or RNS. Therefore, the best classification is DVA with high confidence.
2018-04-27 English
Galapagos reports first quarter 2018 results
Earnings Release Classification · 95% confidence The document is an initial announcement of quarterly financial results (Q1 2018) for Galapagos NV. It contains key financial highlights, management commentary, and a summary table of financial figures. While it mentions that a full online report is available via a link, the document itself provides the substantive financial data and highlights typical of an Earnings Release. It does not meet the criteria for a full Interim Report (which would be a comprehensive filing) nor is it merely a publication announcement, as it provides the actual financial results. Q1 2018
2018-04-26 English
Galapagos reports first quarter 2018 results
Earnings Release Classification · 98% confidence The document is titled "Galapagos rapporteert resultaten eerste kwartaal 2018" (Galapagos reports first quarter 2018 results) and explicitly states it is announcing financial results for the first quarter of 2018. It contains key financial figures (Revenue, Operating Loss, Net Loss, Cash Position) for the period ending March 31, 2018, and includes a detailed table of non-audited core figures for Q1 2018 compared to Q1 2017. This content structure is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it provides the detailed financial highlights and management commentary immediately, it fits the definition of an Earnings Release (ER) which is the initial announcement of periodical financial results. While it contains comprehensive data, the context suggests it is the primary release announcing the period's performance, often preceding a more formal 'Interim Report' (IR) or 10-Q filing, but the immediate presentation of key figures and webcast details strongly points to an ER. The document is substantial (11,801 chars) and contains the results themselves, not just an announcement of the results being available (which would be RPA/RNS). Given the focus on the 'eerste kwartaal' (first quarter) results, 'ER' is the most appropriate classification over 'IR' (which is typically for a more comprehensive, formal report like a half-year report). Q1 2018
2018-04-26 English
Hallmark third quarter 2018 and Annual R&D Update at Galapagos.pdf
Earnings Release Classification · 100% confidence The document is an announcement of quarterly financial results (Q3 2018) for Galapagos NV. It provides key financial highlights, management commentary, and outlook, while explicitly stating that the full Q3 2018 report is available on their website. Since this document serves as the initial announcement of the quarterly results rather than the full report itself, it is classified as an Earnings Release (ER). 9M 2018
2018-04-25 English
Uitstekend derde kwartaal 2018 & jaarlijkse R&D Update bij Galapagos.pdf
Earnings Release Classification · 95% confidence The document is an official announcement from Galapagos NV regarding their financial results for the first nine months of 2018. It contains key financial highlights (revenue, operational loss, net loss, cash position) and a summary table of financial data. While it mentions that a more detailed report is available on their website, the document itself provides substantive financial data and management commentary, which aligns with the definition of an Earnings Release (ER). It is not a full interim report (IR) as it is a summary announcement, and it is not an RPA because it contains the actual financial results rather than just announcing the availability of a report. 9M 2018
2018-04-25 Dutch

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.